Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD

Robert Roberts; MacKenna Roberts

doi:10.14797/mdcvj.1851

Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD

Methodist DeBakey Cardiovascular Journal

Volume 22 (2026): Issue 4

By: Robert Roberts and MacKenna Roberts

Open Access

|Sep 2026

Murray CJL, Lopez AD. Measuring the Global Burden of Disease. N Engl J Med. 2013 Aug 1;369(5):448-457. doi: 10.1056/NEJMra1201534
Open DOI Search in Google Scholar Back to article
World Heart Federation [Internet]. Geneva, Switzerland: World heart Federation; c2026. Deaths from cardiovascular disease surged 60% globally over the last 30 years: Report; 2023 May 20 [cited 2026 Jul 25]. Available from: https://world-heart-federation.org/news/deaths-from-cardiovascular-disease-surged-60-globally-over-the-last-30-years-report/
Search in Google Scholar Back to article
Cohen DE. Balancing cholesterol synthesis and absorption in the gastrointestinal tract. J Clin Lipidol. 2008 Apr;2(2):S1-S3. doi: 10.1016/j.jacl.2008.01.004
Open DOI Search in Google Scholar Back to article
Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest. 2002 Oct;110(7):905-911. doi: 10.1172/JCI16452
Open DOI Search in Google Scholar Back to article
Luo J, Yang H, Song B-L. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245. doi: 10.1038/s41580-019-0190-7
Open DOI Search in Google Scholar Back to article
Tabas I. Free cholesterol-induced cytotoxicity a possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends Cardiovasc Med. 1997 Oct;7(7):256-263. doi: 10.1016/S1050-1738(97)00086-8
Open DOI Search in Google Scholar Back to article
Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 1995 Mar 17;270(11):5772-5778. doi: 10.1074/jbc.270.11.5772
Open DOI Search in Google Scholar Back to article
Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009 Feb;10(2):109-121. doi: 10.1038/nrg2481
Open DOI Search in Google Scholar Back to article
Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144
Open DOI Search in Google Scholar Back to article
Borén J, Chapman MJ, Krauss RM, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962
Open DOI Search in Google Scholar Back to article
Navar-Boggan AM, Peterson ED, D’Agostino RB, Neely B, Sniderman AD, Pencina MJ. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015 Feb 3;131(5):451-458. doi: 10.1161/CIRCULATIONAHA.114.012477
Open DOI Search in Google Scholar Back to article
Aragam KG, Dobbyn A, Judy R, et al. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease. J Am Coll Cardiol. 2020 Jun 9;75(22):2769-2780. doi: 10.1016/j.jacc.2020.04.027
Open DOI Search in Google Scholar Back to article
Zeitouni M, Nanna MG, Sun J-L, Chiswell K, Peterson ED, Navar AM. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults. J Am Coll Cardiol. 2020 Aug 11;76(6):653-664. doi: 10.1016/j.jacc.2020.06.030
Open DOI Search in Google Scholar Back to article
Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3
Open DOI Search in Google Scholar Back to article
D’Agostino RB, Vasan RS, Pencina MJ, et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-753. doi: 10.1161/CIRCULATIONAHA.107.699579
Open DOI Search in Google Scholar Back to article
Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007 Feb 14;297(6):611-619. doi: 10.1001/jama.297.6.611
Open DOI Search in Google Scholar Back to article
Assimes TL, Roberts R. Genetics: Implications for Prevention and Management of Coronary Artery Disease. J Am Coll Cardiol. 2016 Dec 27;68(25):2797-2818. doi: 10.1016/j.jacc.2016.10.039
Open DOI Search in Google Scholar Back to article
Erdmann J, Kessler T, Munoz Venegas L, Schunkert H. A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res. 2018 Jul 15;114(9):1241-1257. doi: 10.1093/cvr/cvy084
Open DOI Search in Google Scholar Back to article
Schunkert H, Natarajan P, Samani NJ. The Inherited Basis of Coronary Artery Disease. N Engl J Med. 2026 Feb 5;394(6):576-587. doi: 10.1056/NEJMra2405153
Open DOI Search in Google Scholar Back to article
Chuong M, Thompson D, Weale ME, et al. Preventing premature deaths through polygenic risk scores. Nat Commun. 2026 Jan 21;17(1):1379. doi: 10.1038/s41467-025-68129-x
Open DOI Search in Google Scholar Back to article
Virmani R, Robinowitz M, Geer JC, Breslin PP, Beyer JC, McAllister HA. Coronary artery atherosclerosis revisited in Korean war combat casualties. Arch Pathol Lab Med. 1987 Oct;111(10):972-976. PMID: 3307684.
Search in Google Scholar Back to article
Joseph A, Ackerman D, Talley JD, Johnstone J, Kupersmith J. Manifestations of coronary atherosclerosis in young trauma victims--an autopsy study. J Am Coll Cardiol. 1993 Aug;22(2):459-467. doi: 10.1016/0735-1097(93)90050-b
Open DOI Search in Google Scholar Back to article
Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults. N Engl J Med. 1998 Jun 4;338(23):1650-1656. doi: 10.1056/NEJM199806043382302
Open DOI Search in Google Scholar Back to article
Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association. Circulation. 2015 Jan 27;131(4). doi: 10.1161/CIR.0000000000000152
Open DOI Search in Google Scholar Back to article
Rahban H, Solsi A, Bies R, et al. Quantification of Coronary Atherosclerosis in the Pre-Peri Menopausal Female Based on Cardiac CCTA. Int J Clin Cardiol Cardiovasc Interv. 2024;4(1). doi: 10.61148/2836-2837/IJCCI/078
Open DOI Search in Google Scholar Back to article
Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol. 1996 Mar 15;77(8):575-580. doi: 10.1016/s0002-9149(97)89309-5
Open DOI Search in Google Scholar Back to article
Shapiro MD, Bhatt DL. “Cholesterol-Years” for ASCVD Risk Prediction and Treatment. Am Coll Cardiol. 2020 Sep 29;76(13):1517-1520. doi: 10.1016/j.jacc.2020.08.004
Open DOI Search in Google Scholar Back to article
Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol. 2012 Dec 25;60(25):2631-2639. doi: 10.1016/j.jacc.2012.09.017
Open DOI Search in Google Scholar Back to article
Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of Lipids on Cardiovascular Health. J Am Coll Cardiol. 2018 Sep 4;72(10):1141-1156. doi: 10.1016/j.jacc.2018.06.046
Open DOI Search in Google Scholar Back to article
Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558
Open DOI Search in Google Scholar Back to article
Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 Oct 8;366(9493):1267-1278. doi: 10.1016/S0140-6736(05)67394-1
Open DOI Search in Google Scholar Back to article
Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5
Open DOI Search in Google Scholar Back to article
Cholesterol Treatment Trialists’ (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010 Nov 13;376(9753):1670-1681. doi: 10.1016/S0140-6736(10)61350-5
Open DOI Search in Google Scholar Back to article
Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, et al. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA. 2016 Sep 27;316(12):1289-1297. doi: 10.1001/jama.2016.13985
Open DOI Search in Google Scholar Back to article
Chan L, Boerwinkle E. Gene-Environment Interactions and Gene Therapy in Atherosclerosis. Cardiol Rev. 1994 May;2(3):130-137.
Search in Google Scholar Back to article
Roberts R, Chang CC. A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease. Curr Genomics. 2020 Aug;21(5):382-398. doi: 10.2174/1389202921999200630145241
Open DOI Search in Google Scholar Back to article
International HapMap Consortium; Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007 Oct 18;449(7164):851-861. doi: 10.1038/nature06258
Open DOI Search in Google Scholar Back to article
McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007 Jun 8;316(5830):1488-1491. doi: 10.1126/science.1142447
Open DOI Search in Google Scholar Back to article
Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007 Jun 8;316(5830):1491-1493. doi: 10.1126/science.1142842
Open DOI Search in Google Scholar Back to article
The Wellcome Trust Case Control Consortium, Burton PR, Clayton DG, Cardon LR, et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007 Jun 7;447(7145):661-678. doi: 10.1038/nature05911
Open DOI Search in Google Scholar Back to article
Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007 Aug 2;357(5):443-453. doi: 10.1056/NEJMoa072366
Open DOI Search in Google Scholar Back to article
Preuss M, König IR, Thompson JR, et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls. Circ Cardiovasc Genet. 2010 Oct;3(5):475-483. doi: 10.1161/CIRCGENETICS.109.899443
Open DOI Search in Google Scholar Back to article
Aragam KG, Jiang T, Goel A, et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat Genet. 2022 Dec;54(12):1803-1815. doi: 10.1038/s41588-022-01233-6
Open DOI Search in Google Scholar Back to article
Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017 Jun;18(6):331-344. doi: 10.1038/nrg.2016.160
Open DOI Search in Google Scholar Back to article
Roberts R, Fair J. A Less than Provocative Approach for the Primary Prevention of CAD. J Cardiovasc Transl Res. 2022 Feb;15(1):95-102. doi: 10.1007/s12265-021-10144-6
Open DOI Search in Google Scholar Back to article
Mega JL, Stitziel NO, Smith JG, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015 Jun 6;385(9984):2264-2271. doi: 10.1016/S0140-6736(14)61730-X
Open DOI Search in Google Scholar Back to article
Natarajan P, Young R, Stitziel NO, et al. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting. Circulation. 2017 May 30;135(22):2091-2101. doi: 10.1161/CIRCULATIONAHA.116.024436
Open DOI Search in Google Scholar Back to article
Marston NA, Kamanu FK, Nordio F, et al. Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial. Circulation. 2020 Feb 25;141(8):616-623. doi: 10.1161/CIRCULATIONAHA.119.043805
Open DOI Search in Google Scholar Back to article
Damask A, Steg PG, Schwartz GG, et al. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Circulation. 2020 Feb 25;141(8):624-636. doi: 10.1161/CIRCULATIONAHA.119.044434
Open DOI Search in Google Scholar Back to article
Inouye M, Abraham G, Nelson CP, et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893. doi: 10.1016/j.jacc.2018.07.079
Open DOI Search in Google Scholar Back to article
Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018 Sep;50(9):1219-1224. doi: 10.1038/s41588-018-0183-z
Open DOI Search in Google Scholar Back to article
Khera AV, Emdin CA, Drake I, et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med. 2016 Dec 15;375(24):2349-2358. doi: 10.1056/NEJMoa1605086
Open DOI Search in Google Scholar Back to article
Tikkanen E, Gustafsson S, Ingelsson E. Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study. Circulation. 2018 Jun 12;137(24):2583-2591. doi: 10.1161/CIRCULATIONAHA.117.032432
Open DOI Search in Google Scholar Back to article
Li L, Pang S, Starnecker F, Mueller-Myhsok B, Schunkert H. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease. Eur Heart J. 2024 May 27;45(20):1843-1852. doi: 10.1093/eurheartj/ehae048
Open DOI Search in Google Scholar Back to article
Samani NJ, Beeston E, Greengrass C, et al. Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting. Eur Heart J. 2024 Sep 7;45(34):3152-3160. doi: 10.1093/eurheartj/ehae342
Open DOI Search in Google Scholar Back to article
Abifadel M, Varret M, Rabès J-P, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003 Jun;34(2):154-156. doi: 10.1038/ng1161
Open DOI Search in Google Scholar Back to article
Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet. 2005 Feb;37(2):161-165. doi: 10.1038/ng1509
Open DOI Search in Google Scholar Back to article
Roberts R. Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval. JACC Basic Transl Sci. 2018 Nov 12;3(5):690-703. doi: 10.1016/j.jacbts.2018.08.001
Open DOI Search in Google Scholar Back to article
Prince AER, Eckel T. Genetic information in insurance: Guiding questions for state regulation. Science. 2026 Feb 26;391(6788):872-874. doi: 10.1126/science.aee2317
Open DOI Search in Google Scholar Back to article
U.S. Equal Employment Opportunity Commission [Internet]. Washington, DC: U.S. Equal Employment Opportunity Commission; c2026. Genetic Information Nondiscrimination Act of 2008; 2008 [cited 2026 Apr 16]. Available from: https://www.eeoc.gov/statutes/genetic-information-nondiscrimination-act-2008
Search in Google Scholar Back to article
National Human Genome Research Institute [Internet]. Bethesda, MD: National Human Genome Research Institute; c2026. Genetic Discrimination; 2028 [cited 2026 Apr 16]. Available from: https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination
Search in Google Scholar Back to article
Robinson JO, Carroll TM, Feuerman LZ, et al. Participants and Study Decliners’ Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing. J Empir Res Hum Res Ethics. 2016 Feb;11(1):21-30. doi: 10.1177/1556264615624078
Open DOI Search in Google Scholar Back to article
Amendola LM, Robinson JO, Hart R, et al. Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. J Genet Couns. 2018 Sep;27(5):1220-1227. doi: 10.1007/s10897-018-0243-7
Open DOI Search in Google Scholar Back to article
Prince AER. Insurance Risk Classification in an Era of Genomics: Is a Rational Discrimination Policy Rational? Neb Law Rev. 2017;96(3):624-687. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934377/
Search in Google Scholar Back to article
vLex [Internet]. Miami, FL: vLex; c206. Acara v. Banks; 2006 Nov [cited 2026 Apr 16]. Available from: https://case-law.vlex.com/vid/acara-v-banks-no-889713490
Search in Google Scholar Back to article
The All of Us Research Program Investigators. The “All of Us” Research Program. N Engl J Med. 2019 Aug 15;381(7):668-676. doi: 10.1056/NEJMsr1809937
Open DOI Search in Google Scholar Back to article
Verma A, Huffman JE, Rodriguez A, et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science. 2024 Jul 19;385(6706):eadj1182. doi: 10.1126/science.adj1182
Open DOI Search in Google Scholar Back to article
Wang M, Menon R, Mishra S, et al. Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians. J Am Coll Cardiol. 2020 Aug 11;76(6):703-714. doi: 10.1016/j.jacc.2020.06.024
Open DOI Search in Google Scholar Back to article
Ray KK, Molemans B, Schoonen WM, et al. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289. doi: 10.1093/eurjpc/zwaa047
Open DOI Search in Google Scholar Back to article
MedRxiv [Internet]. Cold Springs Harbor, NY: MedRxiv; c2026. Ference BA, Ference TB, Catapano AL, Nicholls SJ, Ray KK. A NATUrally Randomized trial Evaluating a vaccine-like strategy to lower LDL by inhibiting PCSK9 on the lifetime risk of major cardiovascular events (NATURE-PCSK9); 2024 [cited 2026 Jul 29]. doi: 10.1101/2024.06.30.24309740
Open DOI Search in Google Scholar Back to article
Ray KK, Stoekenbroek RM, Kallend D, et al. Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial. JAMA Cardiol. 2019 Nov 1;4(11):1067-1075. doi: 10.1001/jamacardio.2019.3502
Open DOI Search in Google Scholar Back to article
Braunwald E. How to live to 100 before developing clinical coronary artery disease: a suggestion. Eur Heart J. 2022 Jan 31;43(4):249-250. doi: 10.1093/eurheartj/ehab532
Open DOI Search in Google Scholar Back to article
Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 May 19;S0735-1097(25)10254-4. doi: 10.1016/j.jacc.2025.11.016
Open DOI Search in Google Scholar Back to article
Schunkert H, Di Angelantonio E, Inouye M, et al. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology. Eur Heart J. 2025 Apr 15;46(15):1372-1383. doi: 10.1093/eurheartj/ehae649
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1851 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 40 - 50

Submitted on: Apr 20, 2026

Accepted on: May 15, 2026

Published on: Sep 15, 2026

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

coronary artery disease,

CAD,

primary prevention,

polygenic risk score,

genetics,

vaccine,

siRNA

© 2026 Robert Roberts, MacKenna Roberts, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 22 (2026): Issue 4